| Primary |
| Product Used For Unknown Indication |
33.9% |
| Hypercholesterolaemia |
15.8% |
| Hypertension |
10.3% |
| Dyslipidaemia |
8.5% |
| Hyperlipidaemia |
6.7% |
| Blood Cholesterol Increased |
4.8% |
| Congestive Cardiomyopathy |
3.0% |
| Blood Cholesterol |
1.8% |
| Diabetes Mellitus |
1.8% |
| Antiplatelet Therapy |
1.2% |
| Atrial Fibrillation |
1.2% |
| Combined Hyperlipidaemia |
1.2% |
| Dyspnoea Exertional |
1.2% |
| Gout |
1.2% |
| Grand Mal Convulsion |
1.2% |
| Liver Transplant |
1.2% |
| Oligodendroglioma |
1.2% |
| Type 1 Diabetes Mellitus |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
| Type Iia Hyperlipidaemia |
1.2% |
|
| Dyspnoea |
10.2% |
| Weight Decreased |
10.2% |
| Thrombocytopenia |
8.2% |
| Hepatocellular Injury |
6.1% |
| Myalgia |
6.1% |
| Pancreatitis |
6.1% |
| Rhabdomyolysis |
6.1% |
| Vomiting |
6.1% |
| Alopecia |
4.1% |
| Aphasia |
4.1% |
| Arthritis |
4.1% |
| Dysphagia |
4.1% |
| Gastric Banding |
4.1% |
| Liver Injury |
4.1% |
| Pulmonary Fibrosis |
4.1% |
| Renal Failure Acute |
4.1% |
| Adverse Event |
2.0% |
| Alopecia Totalis |
2.0% |
| Autoimmune Thrombocytopenia |
2.0% |
| Bipolar Disorder |
2.0% |
|
| Secondary |
| Hypercholesterolaemia |
24.5% |
| Product Used For Unknown Indication |
15.7% |
| Drug Use For Unknown Indication |
14.1% |
| Hypertension |
8.1% |
| Blood Cholesterol Increased |
7.2% |
| Ill-defined Disorder |
3.2% |
| Dyslipidaemia |
3.1% |
| Acute Myocardial Infarction |
3.0% |
| Diabetes Mellitus |
2.9% |
| Type Iib Hyperlipidaemia |
2.4% |
| Hyperlipidaemia |
2.2% |
| Antiplatelet Therapy |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
| Cardiovascular Event Prophylaxis |
1.9% |
| Congestive Cardiomyopathy |
1.9% |
| Osteoporosis |
1.3% |
| Abdominal Pain Upper |
1.2% |
| Myalgia |
1.2% |
| Myocardial Ischaemia |
1.1% |
| Dyspepsia |
1.0% |
|
| Ventricular Tachycardia |
12.5% |
| Myalgia |
10.6% |
| Dyspnoea |
10.0% |
| Tendonitis |
6.9% |
| Weight Decreased |
6.3% |
| Paraesthesia |
5.6% |
| Swollen Tongue |
5.0% |
| Liver Function Test Abnormal |
4.4% |
| Musculoskeletal Discomfort |
4.4% |
| Nausea |
3.8% |
| Rhabdomyolysis |
3.8% |
| Vitreous Detachment |
3.8% |
| Vomiting |
3.8% |
| Memory Impairment |
3.1% |
| Rash |
3.1% |
| Renal Failure |
3.1% |
| Organising Pneumonia |
2.5% |
| Pancreatitis |
2.5% |
| Pancreatitis Acute |
2.5% |
| Peripheral Sensory Neuropathy |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
25.2% |
| Product Used For Unknown Indication |
21.5% |
| Hypertension |
14.0% |
| Hypercholesterolaemia |
6.4% |
| Diabetes Mellitus |
3.5% |
| Ischaemic Cardiomyopathy |
2.9% |
| Hyperlipidaemia |
2.6% |
| Pain |
2.5% |
| Rheumatoid Arthritis |
2.4% |
| Type 2 Diabetes Mellitus |
2.3% |
| Hiv Infection |
2.1% |
| Blood Cholesterol Increased |
2.0% |
| Myocardial Ischaemia |
1.9% |
| Osteoporosis |
1.9% |
| Dyslipidaemia |
1.8% |
| Coronary Artery Disease |
1.7% |
| Atrial Fibrillation |
1.5% |
| Blood Cholesterol |
1.4% |
| Myocardial Infarction |
1.4% |
| Prophylaxis |
1.3% |
|
| Vomiting |
10.6% |
| Weight Increased |
7.3% |
| Weight Decreased |
6.9% |
| Myalgia |
6.5% |
| Renal Failure Acute |
6.1% |
| Myocardial Infarction |
5.7% |
| Rhabdomyolysis |
5.7% |
| Cerebrovascular Accident |
5.3% |
| Renal Failure |
4.9% |
| Rash |
4.5% |
| Pain In Extremity |
4.1% |
| Pulmonary Embolism |
4.1% |
| Thrombocytopenia |
4.1% |
| Muscle Spasms |
3.7% |
| Nausea |
3.7% |
| Pyrexia |
3.7% |
| Sepsis |
3.7% |
| Eosinophilia |
3.3% |
| Loss Of Consciousness |
3.3% |
| Malaise |
3.3% |
|
| Interacting |
| Hypercholesterolaemia |
49.0% |
| Acute Myocardial Infarction |
15.7% |
| Hypertension |
5.9% |
| Diabetes Mellitus |
3.9% |
| Dyslipidaemia |
3.9% |
| Prophylaxis |
3.9% |
| Anaemia Vitamin B12 Deficiency |
2.0% |
| Cardiovascular Event Prophylaxis |
2.0% |
| Dyspepsia |
2.0% |
| Hypothyroidism |
2.0% |
| Musculoskeletal Stiffness |
2.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.0% |
| Rhinitis |
2.0% |
| Type Iia Hyperlipidaemia |
2.0% |
| Urticaria |
2.0% |
|
| Xanthoma |
29.4% |
| Drug Interaction |
11.8% |
| Haemoglobin Decreased |
5.9% |
| Hepatic Enzyme Increased |
5.9% |
| Hepatitis Fulminant |
5.9% |
| Jaundice |
5.9% |
| Neutropenia |
5.9% |
| Pain |
5.9% |
| Polymyositis |
5.9% |
| Red Blood Cell Sedimentation Rate Increased |
5.9% |
| Rhabdomyolysis |
5.9% |
| Weight Decreased |
5.9% |
|
